RXDX Stock Skyrockets On Promising Results In Inflammatory Bowel Disease
[ad_1] Prometheus Biosciences (RXDX) reported promising results for one of its drugs in two inflammatory disease studies on Wednesday, and RXDX stock catapulted by triple digits. X The company studied…